Posted on February 27, 20232/27/23
Single-Arm Data: Turning Limitations into Strengths with Numbers
Posted on February 8, 20232/8/23
Filling Evidence Gaps Through Consensus: Revisiting the Delphi Technique
Posted on August 29, 20228/29/22
EVERSANA’s Value & Evidence Team’s Work Tops List of Most Read Articles in 2021 in Journal of Comparative Effectiveness Research
Posted on June 7, 20226/7/22
Need for RWE in Consumer Health and Its Impact in Managing Lifecycle of Consumer Health Products
Posted on May 6, 20225/6/22
Case Study: Defining the Rare Disease Patient Journey to Support Commercialization of Therapy
Posted on November 1, 202111/1/21
The Need for RWE Studies in APAC and the Impact on Product Life Cycle Management
Posted on September 17, 20219/17/21
Measuring the Impact of Coordinated Field and Digital Engagement Through Network Influence: An Omnichannel Case Study
Posted on July 14, 20217/14/21
Navigating the Transition to Post-Approval Pharmacovigilance With EVERSANA and ArisGlobal
Posted on June 15, 20216/15/21
PharmaVOICE Webinar: Next Gen Commercialization Model for Oncology
Posted on June 14, 20216/14/21